Story
China's Sunmei Group Pivots from Scale to Brand, CEO Prioritizes Market Segments Over IPO

Summary
Sunmei Digital Intelligence Hotel Group, known for its dominance in China's smaller cities, is culling its portfolio to focus on brand strength and specific consumer scenes, delaying IPO plans to build long-term value, according to CEO Ma Yingyao.
Sunmei Digital Intelligence Hotel Group, a dominant force in China's smaller-city hotel market, is fundamentally shifting its strategy from rapid expansion to brand-centric growth, prioritizing consumer preference in niche segments over sheer hotel count, according to founder and CEO Ma Yingyao in a recent interview with Time Finance.
Known as the "King of County-level Cities," Sunmei grew to 4,300 hotels across 1,884 districts by focusing on underserved markets. However, Ma stated the era of growth through sheer volume is over in China's saturated hospitality sector, where nearly 60% of non-chain hotels face customer loss and profit pressure, according to the China Hotel Association.
A Strategic Shift from Scale to Scene
The company's new focus is on becoming the "user's first choice" within specific market segments, or "scenes," rather than competing broadly on price. Ma explained that the key question has shifted from "how many more hotels can we open?" to "why do consumers choose you?" This has led to a strategic pruning of the company's portfolio to strengthen its core brands.
"We would rather reduce a thousand hotels... to become the user's first choice in three to four segments," Ma said, adding that executive performance is now tied to brand-building metrics. Instead of classifying the market by price tiers, Sunmei is targeting consumer needs like esports, social travel, and short-term resort stays with dedicated brands like its Leishen E-sports Hotel.
Partnering and Investing in a Saturated Market
A cornerstone of this strategy is a deepened partnership with global hospitality giant Accor. Sunmei is introducing several Accor brands to China to target distinct consumer profiles:
Ad- Mövenpick by Accor: High-end resorts
- The Sebel by Accor: High-end hotels and serviced apartments
- JO&JOE by Accor: Mid-range lifestyle and social-focused hotels
- greet by Accor: Mid-range light-resort hotels
Counter to the industry's asset-light trend, Sunmei is also investing in 100 directly-operated hotels in key cities. Ma justified the move by pointing to more favorable real estate conditions, noting that prime property rents have fallen by as much as half, increasing the potential return on investment. As an example, he cited the Shanghai People's Square Mövenpick, which has maintained an average occupancy rate above 92% since its opening.
Global Ambitions and a Patient Approach to IPO
Sunmei is also expanding its own brands, like Shangkeyou, into international markets, initially focusing on Southeast Asia and the Middle East. Ma views this, along with the Accor partnership, as a step toward becoming a global, multi-brand operator akin to Marriott or Hilton.
Regarding a potential public listing, Ma stated the company is not in a hurry. He emphasized that the current priority is establishing strong brand equity and operational excellence across its portfolio. An IPO, he believes, will be a natural consequence of building long-term, stable value, a characteristic of the world's most successful century-old hotel groups.
Read next
More on Stocks
Yujian Group Repurchases 96,500 Shares for HK$406,300
Yujian Group Holdings Limited (HKEX: 02408) announced it has bought back 96,500 of its own shares for a total consideration of HK$406,300, according to a company filing on September 24.

Spring REIT Repurchases 80,000 Units for HK$106,600
Spring REIT, a Hong Kong-listed real estate investment trust, announced it bought back 80,000 of its own fund units on September 24 for a total consideration of HK$106,600.

China Shenhua to Pay Final Dividend of RMB 0.98 Per Share on November 23
China Shenhua Energy Co., Ltd. (SEHK: 01088) has announced it will distribute a final dividend of RMB 0.98 per share, with the payment scheduled for November 23, 2026.

Bioperfectus Technologies Secures Chinese Approval for Hepatitis C and Chikungunya Test Kits
Jiangsu Bioperfectus Technologies (688399.SH) has received registration certificates from China's National Medical Products Administration for two new nucleic acid detection kits, expanding its portfolio in the in-vitro diagnostics sector.